21.38
Stevanato Group Spa stock is traded at $21.38, with a volume of 191.74K.
It is down -1.43% in the last 24 hours and down -4.00% over the past month.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
See More
Previous Close:
$21.69
Open:
$21.5
24h Volume:
191.74K
Relative Volume:
0.51
Market Cap:
$5.84B
Revenue:
$1.40B
Net Income/Loss:
$164.00M
P/E Ratio:
35.58
EPS:
0.6009
Net Cash Flow:
$-11.09M
1W Performance:
-5.69%
1M Performance:
-4.00%
6M Performance:
+49.09%
1Y Performance:
-20.73%
Stevanato Group Spa Stock (STVN) Company Profile
Name
Stevanato Group Spa
Sector
Industry
Phone
-
Address
-
Compare STVN vs ISRG, BDX, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
STVN
Stevanato Group Spa
|
21.38 | 5.84B | 1.40B | 164.00M | -11.09M | 0.6009 |
|
ISRG
Intuitive Surgical Inc
|
399.52 | 141.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
179.23 | 48.82B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
RMD
Resmed Inc
|
221.89 | 32.01B | 5.54B | 1.52B | 1.74B | 10.37 |
|
ALC
Alcon Inc
|
64.56 | 31.21B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
34.66 | 30.41B | 29.14B | 1.07B | 1.05B | 1.1956 |
Stevanato Group Spa Stock (STVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-03-24 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-22-24 | Initiated | Exane BNP Paribas | Outperform |
| Nov-01-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-26-23 | Initiated | Stephens | Overweight |
| Sep-19-23 | Initiated | CJS Securities | Market Outperform |
| Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-10-21 | Initiated | BofA Securities | Buy |
| Aug-10-21 | Initiated | Citigroup | Buy |
| Aug-10-21 | Initiated | Jefferies | Buy |
| Aug-10-21 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-10-21 | Initiated | Morgan Stanley | Overweight |
| Aug-10-21 | Initiated | Wells Fargo | Overweight |
View All
Stevanato Group Spa Stock (STVN) Latest News
Technical Reactions to STVN Trends in Macro Strategies - Stock Traders Daily
Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring Growth Potential with a 13.71% Upside - DirectorsTalk Interviews
STVN - Finviz
Stevanato Group SpA (STVN) Shares Fall 4.3% -- What GF Score of 87 Tells Investors - GuruFocus
Stevanato Group S.p.A. Ordinary Shares (NYSE:STVN) Detailed Stock Data - The Chronicle-Journal
Stevanato Group (NYSE: STVN) officer may sell 13,649 shares - Stock Titan
Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling an 18% Potential Upside in Healthcare Solutions - directorstalkinterviews.com
(STVN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Squarepoint Ops LLC Acquires 109,702 Shares of Stevanato Group S.p.A. $STVN - MarketBeat
STVN Maintained by UBS -- Price Target Lowered to $23.00 - GuruFocus
UBS Adjusts Price Target on Stevanato Group to $23 From $28, Keeps Neutral Rating - marketscreener.com
Stevanato Group (NYSE:STVN) Coverage Initiated at UBS Group - MarketBeat
Stevanato Group to Participate in Two Upcoming Investor Conferences - Stevanato Group S.p.A. (STVN)
Stevanato Group S.p.A. (STVN) Stock Analysis: Unlocking 21% Potential Upside for Healthcare Investors - DirectorsTalk Interviews
Sage Park Acquires Balda C. Brewer from Stevanato Group - Global Legal Chronicle
Why Does Stevanato Group (NYSE:STVN) Matter in NYSE Composite? - Kalkine Media
Wellington Management Group LLP Makes New Investment in Stevanato Group S.p.A. $STVN - MarketBeat
Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Stevanato Group (STVN) Trades A Subsidiary For Margin Gains And Growth - Yahoo Finance
Co-Creation for GLP-1 RTU Cartridges - Stevanato Group
Trading Systems Reacting to (STVN) Volatility - Stock Traders Daily
Bank of America Corp DE Sells 784,125 Shares of Stevanato Group S.p.A. $STVN - MarketBeat
A Look at Stevanato Group SpA (STVN) After 3.4% Decline -- GF Va - GuruFocus
Riverwater Sees a Market Overreaction in Stevanato Group (STVN) After Oral GLP-1 Launches - Yahoo Finance
Stevanato Group (NYSE:STVN) Shares Gap UpTime to Buy? - MarketBeat
Stevanato Group S.p.A. (STVN) Stock Analysis: Navigating a Potential 18% Upside in the Healthcare Sector - DirectorsTalk Interviews
Stevanato Group: Alina Validates The Container-To-Device Flywheel (NYSE:STVN) - Seeking Alpha
Stevanato Group SpA (STVN) Shares Fall 5.7% -- What GF Score of 87 Tells Investors - GuruFocus
Ranger Investment Management L.P. Makes New $21.44 Million Investment in Stevanato Group S.p.A. $STVN - MarketBeat
Stevanato (STVN) Today: Gains 1.12% to Reach $22.60 at the Close; Levels: the Near-Term Reference Band Stretches From $21.47 to $23.73 in Latest TradingRating Change - careplusvn.com
Stevanato (STVN) Q2 2026 Filing Snapshot: EPS Prints Above Forecast in Latest Trading; Share-Price Check: Shares Finish 0.28% Lower in the Latest ReadingEBITDA Analysis - vinanet.vn
Stevanato Group (STVN) Edges Higher to $21.19, Holding Between Key Support and ResistanceGap Down Bounce Plays - Vinanet
Stevanato Group S.p.A. (STVN) Stock Analysis: A Solid Healthcare Play with a 17.46% Upside Potential - DirectorsTalk Interviews
T. Rowe Price (STVN) cuts Stevanato stake to 3,921 shares, 0.0% - Stock Titan
Artisan Partners (STVN) discloses 2.6M Stevanato shares held for clients - Stock Titan
Stevanato Group S.p.A. (STVN) Stock Forecasts - Yahoo! Finance Canada
Royal Bank of Canada Grows Stock Position in Stevanato Group S.p.A. $STVN - MarketBeat
Trading the Move, Not the Narrative: (STVN) Edition - news.stocktradersdaily.com
Stevanato Group S.p.A. (NYSE:STVN) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Stevanato Group (STVN) Advances 1.94% as Drug Delivery Specialist Holds Above Key SupportFloat Adjusted Cap - vinanet.vn
Stevanato Group (STVN) Could Be 16% Undervalued Following Earnings And Guidance Update - finance.yahoo.com
How Q2 Results and Alina GLP-1 Approvals At Stevanato Group (STVN) Have Changed Its Investment Story - Sahm
Stevanato Group (NYSE:STVN) Director Luciano Santel Sells 2,023 Shares of Stock - MarketBeat
Stevanato Group Director Elisabetta Magistretti Sells Shares to Meet Tax Obligations - Kalkine Media
Stevanato Group (STVN) Stock Looks Cheap On Cash Flow But Pricey On Earnings - finance.yahoo.com
Stevanato Group S.p.A. (STVN): Investor Outlook Reveals 23.83% Potential Upside - DirectorsTalk Interviews
Stevanato Group Q2 Earnings Call Highlights - MarketBeat
Stevanato Group (STVN) Holds Near $20.27 as Range-Bound Trading PersistsAAII Bullish - careplusvn.com
Stevanato Group S.p.A. SEC Filing (Aug 7, 2026) - Stock Titan
Liraglutide combination products using Stevanato Group pen gain European approval - Drug Store News
Stevanato Group SpA (STVN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Stevanato Group Spa Stock (STVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):